Home › Compare › AITUF vs ABBV
AITUF yields 1.96% · ABBV yields 3.06%● Live data
📍 AITUF pulled ahead of the other in Year 7
Combined, AITUF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AITUF + ABBV for your $10,000?
Anritsu Corporation develops, manufactures, and sells electronic measurement instruments and systems for various communications applications in Japan and internationally. It operates through Test and Measurement, Products Quality Assurance, and Others segments. The company's test and measurement products include bit error rate tester and sampling oscilloscope; mobile/wireless communications measuring instruments, such as base station analyzers, Bluetooth and WLAN testers, cable and antenna analyzers, channel emulators/fading simulators, conformance test systems, handset one box testers, land mobile radio products, passive intermodulation analyzers, shield boxes/chambers, and signaling testers; optical measuring instruments comprising OTDRs, optical loss test set/light source/optical power meter products, optical spectrum analyzers, video inspection probes, and accessories; RF microwave measuring instruments, such as peripheral equipment, and power meters and sensors; signal generators; and signal/spectrum analyzers, vector network analyzers, and transport and ethernet testing products. It also provides X-Ray inspection systems, checkweighers, automatic combination weighers, and metal detectors for the food, pharmaceutical, and cosmetics industries, as well as service assurance solutions; designs and produces precision microwave components; and comprehensive production management system. In addition, the company offers optical sensing for industry and healthcare sectors; optical devices for communication sector; and electron devices. Further, it engages in the environmental measurement, logistics, welfare services, real estate leasing, corporate administration, and part manufacturing and other businesses. The company was founded in 1895 and is headquartered in Atsugi, Japan.
Full AITUF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.